Vicore Pharma Holding AB (VCRE) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 11 79 sessions, July 6, 2026 to October 30, 2026
- Largest daily move
- +11.2% close of October 22, 2026
- 1-month change
- +3% closing prices, September 30, 2026 to October 30, 2026
Company Description
Vicore Pharma Holding AB (NASDAQ: VCRE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $276.0M.
VCRE has gained 3.0% over the past month. The last closing price was $9.80.
This page collects what Stock Titan holds for VCRE, including price data, latest news, SEC filings, upcoming events, and short interest trends.
Stock Performance
Vicore Pharma Holding AB (VCRE) closed at $9.80 on October 30, 2026. Over the past month, the price has gained 3.0%.
VCRE Metrics & Rankings
Price returns through October 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Vicore Pharma Holding AB has 9 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial. View all VCRE news →
SEC Filings
Vicore Pharma Holding AB has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VCRE SEC filings →
Financial Highlights
Upcoming Events
ASPIRE topline results
Topline results release
Vicore Pharma Holding AB has 2 upcoming scheduled events. The next event, "ASPIRE topline results", is expected in 2027. Investors can track these dates to stay informed about potential catalysts that may affect the VCRE stock price.
Short Interest History
Short interest in Vicore Pharma Holding AB (VCRE) currently stands at 1.0 thousand shares, down 75.7% from the previous reporting period, representing 0.0% of the float. Since July 2026, short interest has decreased by 93.6%.
Days to Cover History
Days to cover for Vicore Pharma Holding AB (VCRE) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 5.4 days.
VCRE Company Profile & Sector Positioning
Vicore Pharma Holding AB (VCRE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing VCRE often look at related companies in the same sector, including Eikon Therapeutics, Inc. (EIKN), Fulcrum Therapeutics, Inc. (FULC), Lyell Immunopharma, Inc. (LYEL), Rocket Pharmaceuticals, Inc. (RCKT), and Century Therapeutics, Inc. (IPSC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VCRE's relative position within its industry.